• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HOLOGIC, INC MYOSURE HYSTEROSCOPIC TISSUE REMOVAL; UTERINE TISSUE REMOVAL SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HOLOGIC, INC MYOSURE HYSTEROSCOPIC TISSUE REMOVAL; UTERINE TISSUE REMOVAL SYSTEM Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Death (1802)
Event Date 09/09/2019
Event Type  Death  
Manufacturer Narrative
Date of death is unknown.Brand name of device is unknown.Model number of device is unknown.Lot and serial number of the disposable device not provided by the complainant, therefore the expiration date is not known.The device is not being returned therefore, a failure analysis of the complaint device cannot be completed.If additional relevant information is received or device evaluation completed, a supplemental medwatch will be filed.510k number is unknown.Lot number of the disposable device not provided by the complainant, therefore the manufacture date is not known.Device history record (dhr) review was unable to be conducted for the disposable device as the identification numbers were not provided by the complainant.
 
Event Description
It was reported that a (b)(6) year old patient underwent an uncomplicated fibroid removal procedure.The deficit slowly rose to 2,000 ml by end of the procedure, but there were no "specific distension issues reported." post procedure, on same day, the patient complained of abdominal tenderness and did not "bounce back" as expected and subsequently remained at the facility for a remainder of time.When the tissue removed during the procedure was biopsied, a small portion of bowel was found in the tissue trap.Upon further observation, patient became septic and began to experience "the cardiac related issues," no details on specifics known.Later on, at an unknown date and time, the physician decided to perform an exploratory laparotomy.It was during this procedure that the patient expired.No hologic products were utilized during the laparotomy.Attempts to obtain additional information have been unsuccessful.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MYOSURE HYSTEROSCOPIC TISSUE REMOVAL
Type of Device
UTERINE TISSUE REMOVAL SYSTEM
Manufacturer (Section D)
HOLOGIC, INC
250 campus drive
marlborough MA 01752
Manufacturer Contact
kelsea lyver
250 campus drive
marlborough, MA 01752
5082636130
MDR Report Key9324449
MDR Text Key166437806
Report Number1222780-2019-00256
Device Sequence Number1
Product Code HIH
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 10/28/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/14/2019
Is this an Adverse Event Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/28/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
AQUILEX, SN UNKNOWN
Patient Outcome(s) Death; Hospitalization; Required Intervention;
-
-